// App-Quantinova.ai

: THE VALUE OF WHOLE TRANSCRIPTOME SEQUENCING FOR THE DETECTION OF RECURRENT AND NOVEL FUSION TRANSCRIPTS, COPY NUMBER ABERRATIONS AND SMALL NUCLEOTIDE VARIANTS IN ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Claudia Haferlach

Principal Investigators

  • Rabia Shahswar

  • Constance Baer

  • Wencke Walter

  • Sven O. Twardziok

  • Stephan Hutter

  • Manja Meggendorfer

  • Wolfgang Kern

  • Torsten Haferlach

  • Anna Stengel

Medical Centers

  • Munich Leukemia Laboratory, Munich, Germany.

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • STAR syndrome

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A